Back to Search
Start Over
Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
- Source :
- BMC Family Practice, BMC Family Practice, Vol 9, Iss 1, p 14 (2008)
- Publication Year :
- 2008
-
Abstract
- Background Screening of primary care patients at risk for left ventricular systolic dysfunction by a simple blood-test might reduce referral rates for echocardiography. Whether or not natriuretic peptide testing is a useful and cost-effective diagnostic instrument in primary care settings, however, is still a matter of debate. Methods N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, clinical information, and echocardiographic data of left ventricular systolic function were collected in 542 family practice patients with at least one cardiovascular risk factor. We determined the diagnostic power of the NT-proBNP assessment in ruling out left ventricular systolic dysfunction and compared it to a risk score derived from a logistic regression model of easily acquired clinical information. Results 23 of 542 patients showed left ventricular systolic dysfunction. Both NT-proBNP and the clinical risk score consisting of dyspnea at exertion and ankle swelling, coronary artery disease and diuretic treatment showed excellent diagnostic power for ruling out left ventricular systolic dysfunction. AUC of NT-proBNP was 0.83 (95% CI, 0.75 to 0.92) with a sensitivity of 0.91 (95% CI, 0.71 to 0.98) and a specificity of 0.46 (95% CI, 0.41 to 0.50). AUC of the clinical risk score was 0.85 (95% CI, 0.79 to 0.91) with a sensitivity of 0.91 (95% CI, 0.71 to 0.98) and a specificity of 0.64 (95% CI, 0.59 to 0.67). 148 misclassifications using NT-proBNP and 55 using the clinical risk score revealed a significant difference (McNemar test; p < 0.001) that was based on the higher specificity of the clinical risk score. Conclusion The evaluation of clinical information is at least as effective as NT-proBNP testing in ruling out left ventricular systolic dysfunction in family practice patients at risk. If these results are confirmed in larger cohorts and in different samples, family physicians should be encouraged to rely on the diagnostic power of the clinical information from their patients.
- Subjects :
- Male
medicine.medical_specialty
medicine.drug_class
030204 cardiovascular system & hematology
Logistic regression
Risk Assessment
Sensitivity and Specificity
Coronary artery disease
03 medical and health sciences
Ventricular Dysfunction, Left
0302 clinical medicine
McNemar's test
systolic dysfunction
natriuretic peptide testing
Risk Factors
Internal medicine
Germany
Natriuretic Peptide, Brain
medicine
Natriuretic peptide
Humans
030212 general & internal medicine
Exertion
Risk factor
Aged
lcsh:R5-920
Framingham Risk Score
Primary Health Care
business.industry
Reproducibility of Results
Middle Aged
medicine.disease
3. Good health
Logistic Models
ROC Curve
Echocardiography
Cardiology
Female
business
Risk assessment
lcsh:Medicine (General)
Family Practice
Research Article
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- BMC Family Practice, BMC Family Practice, Vol 9, Iss 1, p 14 (2008)
- Accession number :
- edsair.doi.dedup.....d2b166cd168d50e532251df996bacd2c